Beneficial Role of Imeglimin as Add-on Drug with other Oral Hypoglycaemic Agents for Patients with Type 2 Diabetes: A Single centre Prospective Interventional Study
Introduction: With Type 2 Diabetes Mellitus (T2DM) affecting over 74 million individuals in India alone, achieving glycaemic control remains a persistent challenge, especially in patients inadequately managed with Oral Hypoglycaemic Agents (OHAs). The present study explored the potential of imeglimi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2025-03-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/20700/76512_CE[Ra1]_F(SHU)_QC(SD_SS)_PF1(JY_SL)_PFA(IS)_PB(JY_IS)_PN(IS).pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|